+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antiemetic"

From
From
Diabetic Gastroparesis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Gastroparesis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Gastroparesis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Gastroparesis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Gastrointestinal Over-The-Counter (OTC) Drugs Market 2026-2030 - Product Thumbnail Image

Gastrointestinal Over-The-Counter (OTC) Drugs Market 2026-2030

  • Report
  • January 2026
  • 299 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids. The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more